Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03572400
Brief Title: Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer
First Submitted : June 18, 2018
First Submitted that Met QC Criteria : June 26, 2018
First Posted : June 28, 2018
Last Update Submitted that Met QC Criteria : September 26, 2019
Last Update Posted : September 27, 2019